Skip to content

Mimi Kim

NPI 1629296181ActiveIndividual· Pediatrics, Developmental - Behavioral Pediatrics· Los Angeles, CA

Pediatrics, Developmental - Behavioral Pediatrics in Los Angeles, California, licensed in RI, with an NPI issued in April 2007. Part D covered 25 prescriptions written in 2024, 80% of them generic. Neurocrine Biosciences, Inc. reported $5,337 in payments in 2025, mostly consulting fees.

Overview

NPI1629296181
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedApr 23, 2007
Last updated in NPPESSep 3, 2013

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Developmental - Behavioral Pediatrics Primary2080P0006XMD11516RI

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (CA)

Part D prescriptions in 2024

Prescriptions (claims)25 · 26 30-day fills
Total drug cost$292.38
Generic share80% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$5,337 · 8 payments from 1 company
  • 2024$991.11 · 11 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Neurocrine Biosciences, Inc.$5,3378

What the 2025 payments were for

  • Consulting Fee$5,000 · 1 payment
  • Food and Beverage$336.89 · 7 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Developmental - Behavioral Pediatrics providers in Los Angeles

All Pediatrics, Developmental - Behavioral Pediatrics providers in California →